The Src family of protein tyrosine kinases: regulation and functions. 1993

S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
Differentiation Programme, European Molecular Biology Laboratory, Heidelberg, Germany.

Most of the nine members of the Src family of tyrosine kinases are restricted in their expression, often to cells of the haematopoietic lineage, while some, particularly Src, Fyn and Yes, are more ubiquitously expressed. We have been studying the functions of Src, Fyn and Yes in fibroblasts. We have shown that stimulation of quiescent fibroblasts with platelet-derived growth factor (PDGF) causes Src, Fyn and Yes to become activated, and to associate transiently with the PDGF receptor. To address the role of Src, Fyn and Yes in the response to PDGF, we have used a dominant negative approach, in which cells were engineered to express catalytically inactive forms of Src kinases. These cells were unable to enter S phase in response to PDGF, and we therefore conclude that Src family tyrosine kinases are required in order for the PDGF receptor to transmit a mitogenic signal. It has previously been shown that the kinase activity of Src is negatively regulated by phosphorylation of tyr 527 in its carboxy-terminal tail. A kinase, Csk, that phosphorylates tyr 527 has recently been identified. We expressed Src in yeast to test the model that phosphorylation of tyr 527 represses activity by promoting intramolecular association between the tail and the SH2 domain. Inducible expression of Src in S. pombe caused cell death. Co-expression of Csk counteracted this effect. Src proteins mutated in the SH2 domain were as lethal as wild-type Src, but were insensitive to Csk. We interpret these results in favour of an SH2 domain: phosphorylated tail interaction repressing Src activity. (ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016391 Genes, src Retrovirus-associated DNA sequences (src) originally isolated from the Rous sarcoma virus (RSV). The proto-oncogene src (c-src) codes for a protein that is a member of the tyrosine kinase family and was the first proto-oncogene identified in the human genome. The human c-src gene is located at 20q12-13 on the long arm of chromosome 20. c-src Genes,src Genes,v-src Genes,c-src Proto-Oncogenes,src Gene,src Oncogene,v-src Oncogenes,Gene, c-src,Gene, src,Gene, v-src,Genes, c-src,Genes, v-src,Oncogene, src,Oncogene, v-src,Oncogenes, src,Oncogenes, v-src,Proto-Oncogene, c-src,Proto-Oncogenes, c-src,c src Genes,c src Proto Oncogenes,c-src Gene,c-src Proto-Oncogene,src Oncogenes,v src Genes,v src Oncogenes,v-src Gene,v-src Oncogene

Related Publications

S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
January 1992, Critical reviews in oncogenesis,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
February 1991, International journal of experimental pathology,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
June 1993, Trends in biochemical sciences,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
January 1994, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
July 1996, Molecular and cellular biology,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
January 1992, Ciba Foundation symposium,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
December 1991, The Journal of biological chemistry,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
July 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
August 1994, Seminars in cancer biology,
S A Courtneidge, and S Fumagalli, and M Koegl, and G Superti-Furga, and G M Twamley-Stein
January 1992, Leukemia,
Copied contents to your clipboard!